참고문헌
- Stewart B, Wild CP. World Cancer Report. 2014.
- Horn L, Lovly CM, Johnson DH. Neoplasms of the Lung. In : Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill Education: 2015.
- D'Angelo SP, Janjigian YY, Ahye N, Riely GJ, Chaft JE, Sima CS, et al. Distinct clinical course of EGFR-mutant resected lung cancers:results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib. J Thorac Oncol 2012:7(12):1815-22. https://doi.org/10.1097/JTO.0b013e31826bb7b2
- Lee DH, Srimuninnimit V, Cheng R, Wang X, Orlando M. Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned. Cancer Res Treat 2015:47(4):549-54. https://doi.org/10.4143/crt.2014.362
- Sequist LV, Yang JC, Yamamoto N, O'Byrne K, Hirsh V, Mok T, et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J Clin Oncol 2013:31(27):3327-34. https://doi.org/10.1200/JCO.2012.44.2806
- Yang JC, Hirsh V, Schuler M, Yamamoto N, O'Byrne KJ, Mok TS, et al. Symptom control and quality of life in LUX-Lung 3:a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations. J Clin Oncol 2013:31(27):3342-50. https://doi.org/10.1200/JCO.2012.46.1764
- Park JW, Jun HJ, Cho CK, Lee YW. One Case Study of a Non Small Cell Lung Cancer Patient Experienc ing Gefitinib Adverse Effects Managed by Traditional Korean Medicine. J of Kor Traditional Oncology 2012:17(1):9-16. https://doi.org/10.15432/JKTO.2012.17.1.009
- Yun SJ, Lee JB, Kim KS, Kim YC. Cutaneous Adverse Reactions Induced by Gefitinib (Iressa) in Lung Cancer Patients. Tuberculosis and Respiratory Diseases. 2006:61(2):150-6. https://doi.org/10.4046/trd.2006.61.2.150
- Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, et al. Validation of the Korean version of the EORTC QLQ-C30. Quality of Life Research 2004:13(4):863-8. https://doi.org/10.1023/B:QURE.0000021692.81214.70
- Lee HJ, Sim HS, Seo JK, Lee D, Sung HS. Cutaneous Adverse Reaction Associatied with Epidermal Growth Factor Receptor Inhibitor. Korean J Dermatol 2011:49(2):131-40.
- Kim YH, Kim YT, Kim HK, Park IG, Wu HG, Song SY, et al. Lung cancer guideline. Korean Association for Lung Cancer 2010.
- Tsimboukis S, Merikas I, Karapanagiotou EM, Saif MW, Syrigos KN. Erlotinib-induced skin rash in patients with non-small-cell lung cancer: pathogenesis, clinical significance, and management. Clinical lung cancer 2009:10(2):106-11. https://doi.org/10.3816/CLC.2009.n.013
- Kim KS, Jung TY, Yoo HS, Lee YW, Cho CK. Case Series of Advanced Non-small Cell Lung Cancer Patients Treated with Hang-Am-Plus. Korean J OrientInt Med 2009:30(4):893-900.
- Son JY, Choi GH, Yoo HJ, Kim HJ, Goo JW, Park MY, et al. One Clinical Case Report of Lung Cancer Patient with Dyspnea Prescribed Oriental Medicine. Korean J Orient Int Med 2009:30(1):233-40.
- He W, Cheng M. Meta-analysis on effectiveness and safety of traditional Chinese medicine combined with first-generation EGF R-TKI in treating advanced non-small cell lung cancer. China Journal of Chinese Materia 2017:42(13):2591-8.
- Zhang X, Zhao Y. TCM differentiation and treatment of non-small cell lung cancer targeted drug-related dermal toxicity. J Tradit Chin Med 2015:56(12):1065-6.
- Jeon BH. Influence of the extract of RADIX ASTRAGALI on the cytotoxicity induced by the chemotherapeutic agents, mitomycion C. J Physiol & Pathol Korean Med 1998:12(1):55-9.
- Lee JY, Park HY, Yeom MH, Kim DH, Kim HK. The Protective Effects of Astragali Radix Against UV Induced Cellular Damage in Human Keratinocytes. Kor J Pharmacogn 2008:39(4):300-4.
-
Seo SH, Choi MO. Glycyrrhizae Radix Suppresses Human TNF-
${\alpha}$ -induced Inflammation Via Blockade of p38 Activation in HaCaT Cells. J Kor Soc Cosm 2013:19(2):207-14. - Kasymjanova G, Grossman M, Tran T, Jagoe RT, Cohen V, Pepe C, et al. The potential role for acupuncture in treating symptoms in patients with lung cancer:an observational longitudinal study. Curr Oncol 2013:20(3):152-7. https://doi.org/10.3747/co.20.1312
피인용 문헌
- Afatinib 표적항암치료를 시행 중인 흉막 전이된 비소세포폐암 환자의 한방치료 증례보고 vol.41, pp.6, 2018, https://doi.org/10.22246/jikm.2020.41.6.1255